Kelli M. Luginbuhl

A brush-polymer/exendin-4 conjugate reduces blood glucose levels for up to five days and eliminates poly(ethylene glycol) antigenicity

Yizhi Qi, Antonina Simakova, Nancy J. Ganson et al. · Nature Biomedical Engineering · 2016 · 134 citations

Medicine, Biochemistry, Endocrinology +5

One-week glucose control via zero-order release kinetics from an injectable depot of glucagon-like peptide-1 fused to a thermosensitive biopolymer

Kelli M. Luginbuhl, Jeffrey L. Schaal, Bret R. Umstead et al. · Nature Biomedical Engineering · 2017 · 125 citations · Full text

Pharmacy, Bioengineering, Biomedical Engineering +16

A depot-forming glucagon-like peptide-1 fusion protein reduces blood glucose for five days with a single injection

Miriam Amiram, Kelli M. Luginbuhl, Xueshen Li et al. · Journal of Controlled Release · 2013 · 104 citations

Medicine, Biotechnology, Endocrinology +14

Genetically encoded lipid–polypeptide hybrid biomaterials that exhibit temperature-triggered hierarchical self-assembly

Davoud Mozhdehi, Kelli M. Luginbuhl, Joseph R. Simon et al. · Nature Chemistry · 2018 · 101 citations

Natural Sciences, Bioengineering, Biotechnology +14

Injectable protease-operated depots of glucagon-like peptide-1 provide extended and tunable glucose control

Miriam Amiram, Kelli M. Luginbuhl, Xinghai Li et al. · Proceedings of the National Academy of Sciences · 2013 · 94 citations · Full text

Pharmacy, Biotechnology, Pharmaceutical Biotechnology +17